Global Erectile Dysfunction Treatment Market Insights Report 2024-2029 Featuring Leading Vendors - Bayer, Pfizer, Coloplast, Eli Lilly and Company, and Boston Scientific

News provided by

Feb 09, 2024, 21:45 ET

DUBLIN, Feb. 9, 2024 /PRNewswire/ -- The "Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.

The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%.

The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.

In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.

This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.

Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.

The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.

Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.

The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.

MARKET STRUCTURE

Market Dynamics
Competitive Landscape of ED Treatment Market
Key Vendors
Other Prominent Vendors

VENDORS LIST

Key Vendors

Bayer
Pfizer
Coloplast
Eli Lilly and Company
Boston Scientific

Other Vendors

Teva Pharma
Viatris
Dong-A Socio
Vivus
Cristalia
Dr.Reddy's
Aurobindo
Seelos Therapeutics
Menarini Group
GSK plc
Futura Medical
Sanofi
Cipla
Lupin
Advanz Pharma
Sandoz
IX Biopharma
Domier Medtech
Zephyr Surgical Implants
Augusta Medical Systems
Metuchen Pharmaceuticals
SK Chemicals
Endo International
Ferring Pharmaceuticals
Alembic Pharmaceuticals
Guangzhou Pharmaceuticals
Launch Medical
Bonro Medical
Owen Mumford
Direx Group
Zimmer Medizin Systems
MTS Medical UG
Medispec
Inceler Medical
NOVAmedtek
Wikkon
Top Quality Group
Promedon
Timm Medical Technologies
Global Life Technologies
Urology Health Store
Hims

PRODUCT SEGMENTATION & FORECAST

Product type
Drugs

Route of Administration

Oral Drugs
Penile Injections
Topical Drugs

Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Portals
Devices

Type

Penile Implants
Vacuum Construction Devices
Shock Wave Therapy
Others

For more information about this report visit https://www.researchandmarkets.com/r/9ovjjb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets